Fulcrum shareholders reject stock plan amendment, approve officer liability limitation, elect directors

Fulcrum Therapeutics, Inc.

Stockholders did not approve amendment to 2019 Stock Incentive Plan: 23.7M for, 26.5M against, 48K abstain.
Approved certificate amendment to limit officer liability under Delaware law: 49.0M for, 1.3M against, 16K abstain.
Elected Alan Ezekowitz (41.3M for) and Sonja Banks (42.1M for) as Class I directors for three-year terms.
Ratified Ernst & Young as independent auditor for FY2023: 53.6M for, 8K against, 380K abstain.
Amendment to Restated Certificate filed with Delaware Secretary of State effective June 8, 2023.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Fulcrum Therapeutics, Inc.: Amendment to Restated Certificate of Incorporation to limit liability of certain officers as permitted by recent amendments to Delaware law (effective 2023-06-08).

Change: charter amendment
Effective: 2023-06-08

Exact text from the filing

At the 2023 annual meeting of stockholders of Fulcrum Therapeutics, Inc., or Fulcrum, held on June 8, 2023, or the Annual Meeting, the stockholders of Fulcrum approved an amendment to Fulcrum’s Restated Certificate of Incorporation to limit the liability of certain officers of Fulcrum as permitted by recent amendments to Delaware law. The certificate of amendment of Fulcrum’s Restated Certificate of Incorporation, or Certificate of Amendment, was filed with the Secretary of State of the State of Delaware on June 8, 2023 and became effective upon filing.

View on SEC.gov

Browse all governance changes →

Fulcrum Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-164435

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.